Ab Biosciences, Inc.

Calculating rank

USPTO Granted Patents = 5

EPO Patents = 2

Trademarks = 3

Forward Citations = 5

Loading Chart...

3 inventors (with patents filed for the assignee):

Hsiu-Ching Chang (5 out of 5 patents)

Yen-Ming Hsu (3 out of 26 patents)

Jeng-Shin Lee (3 out of 7 patents)

5 patents: Sort by Forward Citations

1. 11801286 - Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use (2023-10-31),

2. 11304994 - Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for their production and use (2022-04-19),

3. 9624290 - Lowered affinity antibodies and methods of making the same (2017-04-18),

4. 9494597 - Human control antibodies and uses therefor (2016-11-15),

5. 8530629 - Lowered affinity antibodies and uses therefor (2013-09-10),

Company Overview

AB Biosciences, Inc. is a leading biotechnology company specializing in the development and commercialization of innovative products for the life sciences industry. With a focus on advanced research and cutting-edge technologies, AB Biosciences is dedicated to improving the health and well-being of people around the world. Our portfolio includes a diverse range of products and services, from diagnostics and therapeutics to laboratory supplies and equipment. We are committed to delivering high-quality, reliable solutions that meet the evolving needs of our customers and partners.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#25 in Concord, MA

#2,895 in Massachusetts

#51,669 in US

Concord, MA, United States of America

Ab Biosciences, Inc.

Forward Citations = 5

3 inventors:

Hsiu-Ching Chang (5 out of 5 patents)

Yen-Ming Hsu (3 out of 26 patents)

Jeng-Shin Lee (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ab Biosciences, Inc.. Retrieved from https://idiyas.com/company/ab-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]